Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discriminant Ability of the Shock Index, Modified Shock Index, and Reverse Shock Index Multiplied by the Glasgow Coma Scale on Mortality in Adult Trauma Patients: A PATOS Study

NCT05549986 is registered in ClinicalTrials.gov with Mackay Memorial Hospital as lead sponsor.

NCT NCT05549986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05549986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discriminant Ability of the Shock Index, Modified Shock Index, and Reverse Shock Index Multiplied by the Glasgow Coma Scale on Mortality in Adult Trauma Patients: A PATOS Study
Lead sponsor
Mackay Memorial Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2016
Completion date
December 31, 2020
Enrollment
105,641 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

morality, shock, traumatic, trauma